Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial
NRG Oncology/RTOG 0521 3期试验表明,局部高危前列腺癌的转录组分析可改善预后,并揭示在根治性放疗联合雄激素抑制治疗中加入多西他赛的益处。
期刊:European Urology Oncology
影响因子:9.3
doi:10.1016/j.euo.2025.04.009
Phillips, Ryan M; Proudfoot, James A; Davicioni, Elai; Liu, Yang; Spratt, Daniel E; Simko, Jeff M; Den, Robert B; Pollack, Alan; Rosenthal, Seth A; Sartor, A Oliver; Sweeney, Christopher J; Attard, Gerhardt; Longoria, Leslie; Patel, Samir; Straza, Michael W; Efstathiou, Jason A; Shah, Amit B; Hoffman, Karen E; Rodgers, Joseph P; Sandler, Howard M; Feng, Felix Y; Tran, Phuoc T